M
Marilynn Punaro
Researcher at University of Texas Southwestern Medical Center
Publications - 10
Citations - 1336
Marilynn Punaro is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Arthritis & Disease. The author has an hindex of 10, co-authored 10 publications receiving 1238 citations. Previous affiliations of Marilynn Punaro include Texas Scottish Rite Hospital for Children & Children's Medical Center of Dallas.
Papers
More filters
Journal ArticleDOI
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Damien Chaussabel,Charles T. Quinn,Jing Shen,Pinakeen Patel,Casey Glaser,Nicole Baldwin,Dorothee Stichweh,Derek Blankenship,Lei Li,Indira Munagala,Lynda Bennett,Florence Allantaz,Asuncion Mejias,Monica I. Ardura,Ellen Kaizer,Laurence Monnet,Windy Allman,Henry B. Randall,Diane Johnson,Aimee Lanier,Marilynn Punaro,Knut M. Wittkowski,Perrin C. White,Joseph W. Fay,Goran B. Klintmalm,Octavio Ramilo,A. Karolina Palucka,Jacques Banchereau,Virginia Pascual +28 more
TL;DR: This work designed a strategy for microarray analysis that is based on the identification of transcriptional modules formed by genes coordinately expressed in multiple disease data sets that provide a stable framework for the visualization and functional interpretation of microarray data.
Journal ArticleDOI
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade
Florence Allantaz,Damien Chaussabel,Dorothee Stichweh,Lynda Bennett,Windy Allman,Asuncion Mejias,Monica I. Ardura,Wendy K. Chung,Elisabeth Smith,Carol Wise,Karolina Palucka,Octavio Ramilo,Marilynn Punaro,Jacques Banchereau,Virginia Pascual +14 more
TL;DR: Leukocyte transcriptional signatures can be used to distinguish SoJIA from other febrile illnesses and to assess response to therapy and availability of early diagnostic markers may allow prompt initiation of therapy and prevention of disabilities.
Journal ArticleDOI
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman T. Ilowite,Norman T. Ilowite,Oscar Porras,Andreas Reiff,Sue Rudge,Marilynn Punaro,Alan Martin,Roger C. Allen,Terry Harville,Yu Nien Sun,Terry Bevirt,Gary Aras,Brent Appleton +12 more
TL;DR: Results indicate that anakinra 1 mg/kg once daily (≤100 mg/day) is safe and well tolerated in patients with JRA.
Journal ArticleDOI
The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures
Thaschawee Arkachaisri,Soamarat Vilaiyuk,Suzanne C. Li,Kathleen M. O'Neil,Elena Pope,Gloria C. Higgins,Marilynn Punaro,Egla Rabinovich,Margalit Rosenkranz,Daniel Kietz,Paul Rosen,Steven J. Spalding,Teresa Hennon,Kathryn S. Torok,Elaine Cassidy,Thomas A. Medsger +15 more
TL;DR: In this paper, the authors developed and evaluated a Localized Scleroderma (LS) Skin Severity Index (LoSSI) and global assessments' clinimetric property and effect on quality of life (QOL).
Journal ArticleDOI
Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
Suzanne C. Li,Brian M. Feldman,Gloria C. Higgins,Kathleen A. Haines,Marilynn Punaro,Kathleen M. O'Neil +5 more
TL;DR: Most PR in North America treat localized scleroderma with a combination of MTX and corticosteroids, however, there is no consensus on specific treatment regimens and a need for controlled treatment trials to better determine optimal therapy for this potentially disabling disease.